ABIONIC'S SEPSIS DIAGNOSTIC TEST COULD BE USEFUL IN COVID-19 Septic shock is one of the major complications of Covid-19. Vaud-based start-up Abionic, specialized in the miniaturization of diagnostic tests, has developed a test that can detect sepsis in five minutes. Abionic's solution detects sepsis in five minutes, which could be useful for severe cases
Abionic integrates first patients in US clinical trial for sepsis diagnosis method Biopôle, Lausanne, Switzerland, 9th January 2020 – Abionic SA, Swiss Medtech firm based in Lausanne, is initiating a pivotal clinical trial in the US for an innovative point-of-care diagnostic method for sepsis to validate the results of a first trial that took place in
Abionic - Five Minutes To Save Lives
Abionic teams up with Genentech to develop rapid Asthma test Abionic has signed an agreement with Genentech to develop and provide rapid Point-of-Care tests for Asthma in the US. The pre-market process for the specific asthma panel will be managed by Abionic while Genentech will fund clinical and regulatory costs. In the U.S., 25 million
Abionic SA: Revolutionizing the World of In Vitro Diagnostics In 2009, more than 100 million Europeans suffered from allergies. Ironically, the sharp rise in allergy-related conditions of recent decades can be traced back to improved hygiene. European public health systems have identified this surge as one of the main factors that put pressure on their infrastructure. In the biomedical
Abionic Successfully Raises CHF20 Million in Series C Financing Network of Eminent High Net Worth Individuals Join Financing Syndicate Financing to Extend Abionic’s Portfolio of Point-of-Care IVD Tests for Critical Care and Emergency Medicine International Clinical Study of World’s Most Rapid Sepsis Test Starts in 14 Hospitals Source: www.businesswire.com - March 28, 2018
Abionic Announces FDA Registration for World’s Most Rapid Allergy Test and abioSCOPE® Diagnostic Testing Platform Test detects sensitization to four common respiratory allergens in United States Scheduled to be commercially available in the US in 2018 Source: businesswire.com - October 20, 2017 01:00 AM Eastern Daylight Time LAUSANNE, Switzerland--(BUSINESS WIRE)--Abionic SA, a developer of disrupter
World’s Fastest Sepsis Test from Abionic Produces Result in Five Minutes when Tested in patients at London and Zurich Hospitals The UK National Institute for Health and Care Excellence (NICE) is urging hospital staff to treat people with life-threatning sepsis symptoms within one hour University College London Hospitals (UCLH) evaluation highlighted that the
Revolutionary treatment could save thousands of lives, and may soon be introduced in the NHS Sepsis is a life-threatening condition caused by your own body's immune system It occurs when your body overreacts to any infection, even to a small cut or bite The new test has the potential to save hundreds of
PRESS RELEASE: BIOMEDICAL SCREENING DEVICES SOON IN YOUR PHARMACY Source: Abionic.com Biomedical screening devices soon in your pharmacy Lausanne, Switzerland, May 11, 2016 - Starting in November, the AbioSCOPE, a biomedical screening device, in particular for allergies and iron deficiency, will progressively be available in pharmacies in Switzerland. Abionic, the company which developed